Vibalogics, a virotherapy contract development and manufacturing organization (CDMO) focused on the production of live viruses and viral vectors, has announced the completion of its expansion project at its GMP facility in Cuxhaven, Germany. The new building features biosafety level (BSL) 2 Grade B/C cleanrooms supporting host-cell expansion suites, upstream processing capacity at 500L single-use-bioreactor production, and separate downstream purification suites. The increased capacity fur...